EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study

Alison D Marshall iD, Anna Conway, Evan B Cunningham, Heather Valerio, David Silk, Maryam Alavi, Shane Tillakeratne, Alexandra Wade, Thao Lam, Krista Zohrab, Adrian Dunlop iD, Craig Connelly und 7 weitere

Viruses · 2024

DOI: 10.3390/v16111763 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Viruses, 2024. Verfasst von Alison D Marshall und 18 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Hepatitis C, Motivation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health & Medical Research Council (NHMRC) Partnership project grant, National Health & Medical Research Council (NHMRC) Partnership project, Australian Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The primary aim of this study was to establish the feasibility of implementing a larger RCT designed to evaluate the effect of financial incentives on HCV treatment initiation among persons receiving opioid agonist therapy and/or who have injected drugs in the prior six months. ETHOS Engage is an observational cohort of participants recruited from drug treatment and needle and syringe programs in Australia. Among 11 drug and alcohol clinics, participants who were HCV RNA-positive were randomized (1:1) to receive standard of care or a AUD $60 gift card at treatment initiation. Regarding feasibility, 100% (57/57) of eligible participants enrolled to take part. Twenty-eight participants were randomised to the financial incentive arm (AUD $60 gift card) plus standard of care and 29 participants to the standard of care arm. In this pilot RCT (n = 57), median age was 42 years (IQR 37–49), 63% were male (n = 36), 35% Indigenous (n = 20) and 36% (n = 21) reported injecting drugs daily in the past month. Twelve weeks post-study enrolment, 11 (39%) participants in the financial incentive arm and 17 (59%) participants in the standard of care arm initiated HCV treatment. Findings indicate high feasibility among people who inject drugs to be randomised to receive financial incentives to initiate HCV treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse, IntravenousHepatitis CMotivationHumansMaleFemaleAdultPilot ProjectsMiddle AgedAustraliaHepacivirusAntiviral Agents

Stichwörter der Autor:innen

contingency managementfinancial incentivehepatitis C virusrandomised controlled trialtreatment

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia.
  • Centre for Social Research in Health, UNSW Sydney, Sydney, NSW 2052, Australia.
  • Drug and Alcohol Clinical Services, Mid North Coast Local Health District, Kempsey, NSW 2440, Australia.
  • Drug and Alcohol Clinical Services, Western Sydney Local Health District, Sydney, NSW 2770, Australia.
  • Lismore Liver Clinic, Mid North Coast Local Health District, Lismore, NSW 2480, Australia.
  • Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW 2302, Australia.

ORCID-Profile: Alison D Marshall, Adrian Dunlop, Victoria Cock, Michael Christmass, Gregory J Dore, Jason Grebely

Förderung

  • National Health & Medical Research Council (NHMRC) Partnership project grant
  • National Health & Medical Research Council (NHMRC) Partnership project
  • Australian Department of Health
  • NHMRC Investigator
  • Apte Scholarship (UNSW Sydney)
  • Kirby Institute Emerging Investigator
  • Scientia PhD Scholarship

Zitieren

APA

Marshall, A. D., Conway, A., Cunningham, E. B., Valerio, H., Silk, D., Alavi, M., Tillakeratne, S., Wade, A., Lam, T., Zohrab, K., Dunlop, A., Connelly, C., Cock, V., Burns, C., Henderson, C., Christmass, M., Dore, G. J., Grebely, J., & ETHOS Engage Study Group (2024). A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study. Viruses. https://doi.org/10.3390/v16111763

Vancouver

Marshall AD, Conway A, Cunningham EB, Valerio H, Silk D, Alavi M, et al. A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study. Viruses. 2024. doi:10.3390/v16111763

BibTeX
@article{Marshall2024,
  author = {Marshall, Alison D and Conway, Anna and Cunningham, Evan B and Valerio, Heather and Silk, David and Alavi, Maryam and Tillakeratne, Shane and Wade, Alexandra and Lam, Thao and Zohrab, Krista and Dunlop, Adrian and Connelly, Craig and Cock, Victoria and Burns, Carina and Henderson, Charles and Christmass, Michael and Dore, Gregory J and Grebely, Jason and ETHOS Engage Study Group, ETHOS Engage Study Group},
  title = {A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16111763}
}
Kostenlos starten →